Market Value368,224,000
Total Holdings43
File Date2020-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARVN / Arvinas, Inc.
ANNX / Annexon, Inc.
DRNA / Dicerna Pharmaceuticals Inc
QURE / uniQure N.V.
VIR / Vir Biotechnology, Inc.
859319303 / Sterling Financial Corp
GBIO / Generation Bio Co.
FUSN / Fusion Pharmaceuticals Inc.
AKUS / Akouos Inc
XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF Put
KDMN / Kadmon Holdings Inc
CNCE / Concert Pharmaceuticals Inc
RETA / Reata Pharmaceuticals Inc - Class A
CRDF / Cardiff Oncology, Inc.
AXSM / Axsome Therapeutics, Inc.
VINC / Vincerx Pharma, Inc.
LRMR / Larimar Therapeutics, Inc.
RNA / Atrium Therapeutics, Inc.
CBIO / Crescent Biopharma, Inc.
KRTX / Karuna Therapeutics, Inc.
AGEN / Agenus Inc.
BTAI / BioXcel Therapeutics, Inc.
VSTM / Verastem, Inc.
CLSD / Clearside Biomedical, Inc.
TRIL / Tidal Trust II - Defiance Trillion Dollar Club Index ETF
MRSN / Mersana Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
RLMD / Relmada Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
ADVM / Adverum Biotechnologies, Inc.
CYTK / Cytokinetics, Incorporated
SURF / Surface Oncology Inc
/ Immunomedics, Inc.
NUVB / Nuvation Bio Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
SELB / Selecta Biosciences Inc
COGT / Cogent Biosciences, Inc.
ALDX / Aldeyra Therapeutics, Inc.
MRUS / Merus N.V.
HSAQ / Health Sciences Acquisitions Corp 2
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
CLDX / Celldex Therapeutics, Inc.
ATHA / LeonaBio, Inc.
XENE / Xenon Pharmaceuticals Inc.
AVDL / Avadel Pharmaceuticals plc
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
CBAY / CymaBay Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
ALT / Altimmune, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
IMVT / Immunovant, Inc.
APLT / Applied Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
BLU / Bellus Health Inc
ASND / Ascendis Pharma A/S
ETNB / 89bio, Inc.
FULC / Fulcrum Therapeutics, Inc.